Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/57113
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDharmapatni, Kencanaen
dc.date.issued2007en
dc.identifier.urihttp://hdl.handle.net/2440/57113-
dc.description.abstractApoptosis and inflammation have been considered to be linked mechanisms. Defective apoptosis may result in cell accumulation and prolonged half life of inflammatory cells in rheumatoid arthritis (RA). A similar phenomenon is seen in malignancy. Therefore, defects in apoptosis pathways that have been proposed to contribute to the pathogenesis of malignancy may also be seen in RA. It has been reported by many studies that treatments that induce apoptosis of malignant cells are advantageous for cancer treatment and this suggests that targeting apoptosis pathways may be important in the management of a variety of pathologies that involve abnormalities in cell proliferation. While apoptosis induction has been a common mechanism in the treatment of cancer, it has only recently been seriously considered to be effective in regulating proliferative cells in inflammation. This thesis provides important information regarding the TRAIL mediated pathway of apoptosis and possible factors that modulate the ability of this pathway to induce apoptosis in RA.en
dc.subjectapoptosis; rheumatoid arthritisen
dc.titleTRAIL mediated apoptosis in arthritis.en
dc.typeThesisen
dc.contributor.schoolSchool of Medical Sciences : Pathologyen
dc.provenanceFull text not available, contact Library_theses@adelaide.edu.au-
dc.description.dissertationThesis (Ph.D.) -- University of Adelaide, School of Medical Sciences, 2007en
Appears in Collections:Research Theses

Files in This Item:
File SizeFormat 
09phd5338.pdf75.05 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.